Company Overview and News
Since oil hit the lows of $26.21 a barrel in January of 2016, the price has rebounded sharply, and recently a barrel of West Texas Intermediate reached almost $74 in June. Given that oil has rallied almost 200%, one would think that the prices of energy companies would do the same. While many are off their lows from two and three years ago, a new Baird research report makes the case that many of the top companies are trading at a discount:
XEC CTLR CLR
Crude oil is under pressure on Wednesday, with the U.S. Oil Fund (USO) falling below its 50-day moving average and threatening to fall away from a topping pattern going back to May. The catalyst for the pullback was a big build in gasoline inventories suggesting that summertime driving demand is coming in a little tepid. The inventory accumulation was the first since June.
COP XEC MRO OXY EOG
The time has come for the exploration and production stocks to report earnings, and with Exxon Mobil and Chevron both missing the mark last Friday, the question for investors is where to place their bets. The disappointing results come as much of the U.S. oil industry has been recovering from a three-year downturn in the energy sector, bolstered by higher production and crude prices.
XEC XOM RSPP PXD CXO FANG
We continue our Marketplace Energy Week with insights from Elephant Analytics, who think geopolitical events have the potential to drive up near-term oil prices.
Just when it seemed that oil was ready to head to $80 a barrel, the combination of increased OPEC and Russian production, along with the Saudis putting the production pedal down, has helped to push prices on West Texas Intermediate below $70, and Brent back down near $74. Toss in some jawboning from the U.S. president and some big storage numbers, and that also helped with the slide in pricing.
XEC RSPP CXO
2018-07-11 seekingalpha - 5
Energy producers have flocked to the prolific Permian Basin boosting demand for takeaway capacity and creating serious bottlenecks.
DCP CJ XEC CRLFF DVN REN PE CXO SCAZP EPD ENB MPC ANDV AXAS CRZO AREX KMI RSPP PAA MMP JAG SNZYP KMR CVB SN CDEV NBL MTDR SM BWP HKRCP ESTE PSXP ETP DPM SRE CVX LPI HK TRGP KMRFZ
Once it was the hottest oil and natural gas production region in the United States, and the top companies focused on the Permian Basin in West Texas and New Mexico performed well. Recently though, the ability to transport production has been hampered by pipeline capacity issues. As a result, some of the top Permian stocks have been hit hard, and investors are literally being offered some of the best entry points in years.
This report updates my initial report on the US shale diversified oil-weighted E&Ps with 2018 Q1 results. For definitions of terms and explanations of methodology, please refer to the initial report published on 4/24/2018, U.S. Shale: NAV Analysis Of Diversified Oil-Weighted E&Ps, covering EOG Resources (NYSE:EOG), Devon Energy (NYSE:DVN), Continental Resources (NYSE:CLR), QEP Resources (NYSE:QEP), WPX Energy (NYSE:WPX) and Cimarex Energy (NYSE:XEC).
WPXP XEC CTLR DVN QEP CLR AXAS WPX EOG
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to XEC / Cimarex Energy Co. on message board site Silicon Investor.
as of ET